Team:MIT/rtTA3

From 2013.igem.org

Revision as of 03:58, 28 September 2013 by Lsaint (Talk | contribs)

iGEM 2012

Overview

  • Project Overview

miRNA Signal

  • Overview
  • siRNA Characterization
  • Exosome Isolation and Co-Culturing
  • Cell-Cell Co-Culturing

Protein Signals

  • Overview
  • GFP
  • rtTA3
  • Cre
  • L7Ae
  • Cas9-VP16

Novel DNA Sensor: Cas9 Split Venus Fusion

  • Overview
  • Leucine Zipper Fusion
  • DNA Sensing

Our BioBricks

  • Favorites
  • All BioBricks

Attributions

  • Attributions

Overview

This part functions in the activation of genes in our sender cells. Here, we employ the highly oligomeric cytoplasmic protein TyA with an N-terminal acylation tag (MGCINSKRKD-) to target proteins to exosomes. In this case, the transported protein is a reverse tetracycline-controlled transactivator (rtTA3, here referred to as rtTA) that must be sent to exosomes so that it can be exported to receiver cells.

To test the functionality of rtTA in single cells, a constitutive expression of rtTA was driven by the human elongation factor 1a (hEF1a) promoter. A receiver circuit consisting of mKate fused to tetracycline response element (Tre-tight, or just Tre-t) promoter was also constructed. In theory, the constitutive rtTA would drive the expression of mKate in the presence of doxycycline (DOX). Jurkat T cells were nucleofected with both plasmids and incubated with doxycycline (DOX). The mKate fluorescence was observed 48 hours post nucleofection, proving that the rtTA worked. Then, we assembled two different rtTA constructs - Acyl-TyA-rtTA and Acyl-TyA-rtTA-6xHis - to send via exosomes.

Overall, rtTA is a very useful part. Here, we use it to show that it is possible to both send this construct in an exosome and use it to activate receiver cell genes. This activation does not apply just to fluorescent proteins, like the mKate we used here - it can possibly be used to activate any gene driven by the Tre-t promoter.

Characterization

Since it is such a crucial component in many of our exosomal cargoes, rtTA needed to be tested extensively before we could attempt to send it. In our project, rtTA is used in conjunction with DOX) and the TRE-tight promoter to activate genes—when DOX is absent, rtTA inhibits the promoter; conversely, when DOX is present, rtTA activates the promoter, allowing transcription of our desired protein. In this case, the output of each circuit is a fluorescent protein.

First, we needed to ensure that our rtTA sequence was correct and functional. We transfected HEK-293 cells with three circuits: constitutively expressed rtTA, mKate under the influence of the Tre-t promoter, and constitutively expressed eBFP (used as a transfection marker only). We expected to see red fluorescence when doxycycline was added, and this was indeed the case.

Once we determined that rtTA was functional, we checked the functionality of the Acyl-TyA-rtTA fusion protein. There were concerns that the oligemerization effects of TyA would interfere with the activity of rtTA. We transfected the new Acyl-TyA-rtTA construct into HEK-293 cells, using mKate for the output and eBFP for the transfection marker like in the previous experiment. We found that the fusion rtTA still worked in the presence of DOX.





As previously stated, both rtTA and Acyl-TyA-rtTA worked as we had hoped. The fusion protein had somewhat reduced effectiveness, most likely due to hindrance from TyA; however, its activity was sufficient for our purposes.

The above graph shows the red fluorescence detected for Acyl-TyA-rtTA and the lone rtTA both with and without DOX. With DOX, both rtTA circuits activated the mKate. As mentioned above, rtTA alone (the green line) was more effective, and despite its lower activity, Acyl-TyA-rtTA (the blue line) was also deemed successful. The red and black lines depict the mKate activation due to each protein in the absence of DOX. As expected, there was little to no fluorescence in these cases.

In addition to Acyl-TyA-rtTA, we constructed an Acyl-TyA-rtTA-6xHis protein, where the 6xHis is an appended tag consisting of six histine amino acids. Theoretically, the 6xHis would facilitate the export of the construct into exosomes.

The above graph shows the data from our Acyl-TyA-rtTA-6xHis. Like Acyl-TyA-rtTA, this construct worked as we had expected - sufficient fluorescence was detected in the presence of DOX.

Exosome Isolation and Co-Culturing

Once we confirmed that the Acyl-TyA-rtTA fusion construct was functional, we progressed to exosomal experiments. We transfected Jurkat T cells with our constitutive Acyl-TyA-rtTA, cultured them, and isolated exosomes from them. Concurrently, we cultured HEK-293 cells transfected with our receiver circuits (rtTA-induced mKate and constitutive eBFP). Then, we added DOX and the isolated exosomes to the HEK cells. Initially, we observed a negative result—no mKate was detected—but we still have further optimization to do.



Cell-Cell Co-Culturing

Once we obtain a positive result from the exosome isolation experiment, we will move on to co-culturing the engineered Jurkat sender cells and HEK-293 receiver cells in a single dish. As shown in the graphic below, we expect the Jurkat cells to produce our fusion protein and package it into exosomes. The exosomes will then diffuse throughout the culture medium and, when they encounter the HEK cells, enter them and activate the mKate if DOX is also present.